By P.R.Venkat

Sanofi India Ltd. (500674.BY) said it is planning to sell a pharmaceutical manufacturing facility in the western Indian state of Gujarat to Zentiva.

Sanofi India, a unit of France-based Sanofi S.A. (SAN.FR), is selling the Ankleshwar site for 2.62 billion Indian rupees ($36.4 million), the company said in a statement on Wednesday.

The Ankleshwar site has a chemistry and biotechnology development centre, and manufactures both intermediates and pharmaceutical formulations. Sanofi's Ankleshwar site manufactures more than six billion tablets annually that include painkiller brands like Combiflam.

Write to venkat.pr@wsj.com

(END) Dow Jones Newswires

September 11, 2019 02:31 ET (06:31 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Sanofi
Sanofi (NASDAQ:SNY)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Sanofi